Literature DB >> 30919138

Development of Zinc Chelating Resin Polymer Beads for the Removal of Cell-Free Hemoglobin.

Kelli Simms1, Elisabeth Rebholz1, Robert M Mayberry1, Swati Basu2, Andreas Perlegas2, Martin Guthold2, Daniel B Kim-Shapiro2, Elaheh Rahbar3.   

Abstract

Red blood cell (RBC) hemolysis is one of the most common storage lesions in packed RBCs (pRBC). Older units of pRBCs, especially those > 21 days old, have increasing levels of hemolysis leading to increased oxidative stress and premature platelet activation. This effect can mostly be attributed to the increase of cell-free hemoglobin (Hb). Therefore, removal of cell-free Hb from pRBCs prior to transfusion could mitigate these deleterious effects. We propose a new method for the removal of Hb from pRBCs using zinc beads. Prepared Hb solutions and pRBCs were treated with zinc beads using two different protocols. UV-Vis spectrophotometry was used to determine Hb concentrations, before and after treatment. Experiments were run in triplicate and paired t tests were used to determine significant differences between groups. Zinc beads removed on average 94% of cell-free Hb within 15 min and 78% Hb from pRBCs (p < 0.0001), demonstrating a maximum binding capacity ~ 66.2 ± 0.7 mg Hb/mL beads. No differences in RBC morphology or deformability were observed after treatment. This study demonstrates the feasibility of using zinc beads for the rapid and targeted removal of Hb from pRBC units. Further investigation is needed to scale this method for large volume removal.

Entities:  

Keywords:  Blood products; Hb; Hemolysis; RBC; Transfusion; Zinc resin

Mesh:

Substances:

Year:  2019        PMID: 30919138      PMCID: PMC6506348          DOI: 10.1007/s10439-019-02249-6

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  22 in total

Review 1.  Red blood cell storage: the story so far.

Authors:  Angelo D'Alessandro; Giancarlo Liumbruno; Giuliano Grazzini; Lello Zolla
Journal:  Blood Transfus       Date:  2010-04       Impact factor: 3.443

2.  Current therapy of sickle cell disease.

Authors:  Zakari Y Aliyu; Ashaunta R Tumblin; Gregory J Kato
Journal:  Haematologica       Date:  2006-01       Impact factor: 9.941

3.  Storage lesion: role of red blood cell breakdown.

Authors:  Daniel B Kim-Shapiro; Janet Lee; Mark T Gladwin
Journal:  Transfusion       Date:  2011-04       Impact factor: 3.157

4.  Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion.

Authors:  Chenell Donadee; Nicolaas J H Raat; Tamir Kanias; Jesús Tejero; Janet S Lee; Eric E Kelley; Xuejun Zhao; Chen Liu; Hannah Reynolds; Ivan Azarov; Sheila Frizzell; E Michael Meyer; Albert D Donnenberg; Lirong Qu; Darrel Triulzi; Daniel B Kim-Shapiro; Mark T Gladwin
Journal:  Circulation       Date:  2011-07-11       Impact factor: 29.690

5.  Mechanisms of hemolysis-associated platelet activation.

Authors:  C C Helms; M Marvel; W Zhao; M Stahle; R Vest; G J Kato; J S Lee; G Christ; M T Gladwin; R R Hantgan; D B Kim-Shapiro
Journal:  J Thromb Haemost       Date:  2013-12       Impact factor: 5.824

6.  Interaction of zinc and hemoglobin: binding of zinc and the oxygen affinity.

Authors:  J M Rifkind; J M Heim
Journal:  Biochemistry       Date:  1977-10-04       Impact factor: 3.162

7.  Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light.

Authors:  Susanne Marschner; Raymond Goodrich
Journal:  Transfus Med Hemother       Date:  2011-01-31       Impact factor: 3.747

8.  Nitric oxide formation from nitrite in zebrafish.

Authors:  Frank B Jensen
Journal:  J Exp Biol       Date:  2007-10       Impact factor: 3.312

Review 9.  The essential toxin: impact of zinc on human health.

Authors:  Laura M Plum; Lothar Rink; Hajo Haase
Journal:  Int J Environ Res Public Health       Date:  2010-03-26       Impact factor: 3.390

Review 10.  Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins.

Authors:  Dominik J Schaer; Paul W Buehler; Abdu I Alayash; John D Belcher; Gregory M Vercellotti
Journal:  Blood       Date:  2012-12-20       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.